CD163 and Parkinson disease: In a PD model, rats with 6-OHDA damage treated with glucocorticoids targeting CD163 (a marker of M2 macrophages) shifted brain myeloid cells towards anti-inflammatory (M2-like) phenotypes and protected dopaminergic neurons of the substantia nigra [166].